Who Owns AAPG?
ASCENTAGE PHARMA GROUP INTERNATIONAL — Institutional Ownership & 13F Holdings
$22.20
+0.00 (+0.00%)
Market Cap
$2.2B
Shares Outstanding
23,240,842
Institutional Holders
6
Total Inst. Value
$1.7M
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | Point72 (DIFC) Ltd | $558K | 25,404 |
| 2 | XY Capital Ltd | $516K | 23,505 |
| 3 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | $350K | 15,943 |
| 4 | Verition Fund Management LLC | $218K | 9,922 |
| 5 | UBS Group AG | $54K | 2,478 |
| 6 | Monashee Investment Management LLC | $4K | 159,942 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold AAPG?
As of Q1 2025, 6 institutional investors report holding AAPG (ASCENTAGE PHARMA GROUP INTERNATIONAL) in their 13F filings.
Which hedge fund owns the most AAPG?
The largest institutional holder of AAPG is Point72 (DIFC) Ltd with $558K in shares.
Are institutions buying or selling AAPG?
This quarter, 6 institutions opened new positions in AAPG and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.